June 18, 2015 9:23am
The Bottom line: This will allow expansion of the number of clinical trial sites and patients with spinal cord injury that STEM can include in its ongoing Pathway study.
Members only. Please login.
June 18, 2015 9:23am
The Bottom line: This will allow expansion of the number of clinical trial sites and patients with spinal cord injury that STEM can include in its ongoing Pathway study.
Members only. Please login.
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors